All‐in‐one platform: Versatile, Easy, and User‐friendly System (VEUS) based on automated and expert‐independent antibody immobilization and immunoassay by utilizing customized movement of magnetic particles
Biotechnology Journal · 2024
DOI: 10.1002/biot.202400074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Jinsik Yoon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Wearable Convergence Electronics, College of Electronics and Information, Kyung Hee University, Yongin, Gyeonggi, Republic of Korea. Hauptthemen laut MEDLINE: SARS-CoV-2. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups, National Research Foundation of Korea.
Abstract (Originalsprache)
The ELISA is the most worldwide method for immunoassay. However, the ELISA is losing ground due to low reproducibility of manual experimental processes in both R&D and IVD areas. An automated platform is a good solution, but there are still limitations owning to extremely high cost and requiring large space to set up especially for a small size laboratory. Here, we present a novel all‐in‐one platform called “VEUS” settable on the laboratory table that offers comprehensive automation of the entire multiplex immunoassay process by exploiting antibody conjugated magnetic particles, quality control and then immunoanalytical reaction, thereby enhancing detection sensitivity and high reproducibility. As a proof of concept, the system exhibits a sensitive LOD of 0.6 and 3.1 pg mL −1 within 1 h run, comparable precision that of molecular diagnostic systems based on PCR method, enabling rapid multiplex diagnosis of Influenza A, Influenza B, and COVID‐19 viruses with similar symptoms. Through automation by the all‐in‐one system, it can be used by novice users, something innovative for immunoassays, relying heavily on user experience. Furthermore, it can contribute to streamline entire immunoassay processes of diverse biomarkers with high reproducibility and convenience in laboratories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Wearable Convergence Electronics, College of Electronics and Information, Kyung Hee University, Yongin, Gyeonggi, Republic of Korea.
- EzDiaTech Inc. Anyang, Gyeonggi, Republic of Korea.
- Department of Electronics and Information Convergence Engineering, Kyung Hee University, Yongin, Gyeonggi, Republic of Korea.
- Department of Electronic Engineering, Kyung Hee University, Yongin, Gyeonggi, Republic of Korea.
ORCID-Profile: Junghyun Bae, Yong-Gyun Jung
Förderung
- Ministry of SMEs and Startups
- National Research Foundation of Korea
Zitieren
APA
Yoon, J., Kim, J., Lim, S., Choi, H., Bae, J., Kim, K., Song, S. H., Cho, Y. B., Park, W., & Jung, Y. G. (2024). All‐in‐one platform: Versatile, Easy, and User‐friendly System (VEUS) based on automated and expert‐independent antibody immobilization and immunoassay by utilizing customized movement of magnetic particles. Biotechnology Journal. https://doi.org/10.1002/biot.202400074
Vancouver
Yoon J, Kim J, Lim S, Choi H, Bae J, Kim K, et al. All‐in‐one platform: Versatile, Easy, and User‐friendly System (VEUS) based on automated and expert‐independent antibody immobilization and immunoassay by utilizing customized movement of magnetic particles. Biotechnology Journal. 2024. doi:10.1002/biot.202400074
BibTeX
@article{Yoon2024,
author = {Yoon, Jinsik and Kim, Jiyeong and Lim, Sujeong and Choi, Heelak and Bae, Junghyun and Kim, Kibeom and Song, Suk-Heung and Cho, Yoo-Bok and Park, Wook and Jung, Yong-Gyun},
title = {All‐in‐one platform: Versatile, Easy, and User‐friendly System (VEUS) based on automated and expert‐independent antibody immobilization and immunoassay by utilizing customized movement of magnetic particles},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202400074}
}
EUVIMED